Olizid-TZ 1.125 Injection
Marketer
Fawn Incorporation
Salt Composition
Ceftazidime (1000mg) + Tazobactum (125mg)
Overview Olizid-TZ 1.125 Injection
Combiflox-TZ 1.125 Injection, a dual-action medication, combats diverse bacterial infections by hindering microbial proliferation and halting infection spread. Administered solely under medical supervision, this injection requires adherence to the prescribed schedule. Complete the full treatment course, even with symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Your physician may order lab tests to monitor treatment response.
Uses of Olizid-TZ 1.125 Injection
Infections caused by bacteria
Major Benefits of Olizid-TZ 1.125 Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Olizid-TZ 1.125 Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Olizid-TZ 1.125 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Olizid-TZ 1.125 Injection works:
Olizid-TZ 1.125 Injection merges Ceftazidime, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby amplifying Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Olizid-TZ 1.125 Injection may be used concomitantly with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation Olizid-TZ 1.125 is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to the fetus; however, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Olizid-TZ 1.125 Injection while breastfeeding is considered safe. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Administering Olizid-TZ 1.125 Injection can induce drowsiness, visual disturbances, and dizziness. Driving is prohibited should these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administration of Olizid-TZ 1.125 Injection requires careful monitoring. Dosage modification of Olizid-TZ 1.125 Injection might be necessary; physician consultation is advised.
LiverCAUTION
Administering Olizid-TZ 1.125 Injection to individuals with advanced hepatic impairment requires careful consideration. Dosage modification for Olizid-TZ 1.125 Injection might be necessary. Physician consultation is recommended.
What if you forget to take Olizid-TZ 1.125 Injection :
Should you forget a scheduled Olizid-TZ 1.125 Injection, seek medical advice.
Facts to Know About Olizid-TZ 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently